Virginiamycin S1 is a novel, potent and naturally occurring cyclic hexadepsipeptide antibiotic that inhibits bacterial protein synthesis at the level of aminoacyl-tRNA binding and peptide bond formation. Virginiamycin S1 is produced by Streptomyces virginiae, and shows a strong bactericidal activity against a wide range of Gram-positive bacteria. Effective in treat multidrug-resistant bacterial infections.

TAMRA-PEG4-tetrazine is a novel and potent PROTAC linker

5-Aminofluorescein (5-AF) is a novel fluorescence marker that covalently binds to human serum albumin (AFL-HSA). It is a pH-sensitive biomaterial used as a targeted prodrug for synthesis of FA-FITC-Arg-PTX and FA-5AF- Glu-PTX.

NucPE1 is a novel and potent fluorescent hydrogen peroxide

(R)-Simurosertib is a novel and potent cycle 7 (CDC7) kinase inhibitor

Fingolimod phosphate (FTY-720-P) is the phosphate salt of Fingolimod (FTY-720; FTY 720; Gilenia and Gilenya) with improved water solubility. Fingolimod is an FDA approved drug for the treatment of Multiple sclerosis, acting as a S1P (sphingosine 1-phosphate) antagonist with potential antineoplastic activity. It inhibits S1P with an IC50 of 0.033 nM in K562 and NK […]

Ropivacaine mesylate is a novel and potent aminoamide compound

Ald-Ph-amido-C2-PEG3-azide is a novel and potent PROTAC linker

SMYD2-IN-1 is a novel and potent SMYD2 inhibitor

DBCO-NHCO-PEG12-biotin is a novel and potent PROTAC linker